Historical Valuation
Biote Corp (BTMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.41 is considered Fairly compared with the five-year average of 4.09. The fair price of Biote Corp (BTMD) is between 1.66 to 4.82 according to relative valuation methord.
Relative Value
Fair Zone
1.66-4.82
Current Price：2.58
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Biote Corp (BTMD) has a current Price-to-Book (P/B) ratio of -1.04. Compared to its 3-year average P/B ratio of -2.58 , the current P/B ratio is approximately -59.66% higher. Relative to its 5-year average P/B ratio of -2.07, the current P/B ratio is about -49.62% higher. Biote Corp (BTMD) has a Forward Free Cash Flow (FCF) yield of approximately 43.14%. Compared to its 3-year average FCF yield of 16.84%, the current FCF yield is approximately 156.20% lower. Relative to its 5-year average FCF yield of 13.23% , the current FCF yield is about 226.10% lower.
P/B
Median3y
-2.58
Median5y
-2.07
FCF Yield
Median3y
16.84
Median5y
13.23
Competitors Valuation Multiple
AI Analysis for BTMD
The average P/S ratio for BTMD competitors is 0.40, providing a benchmark for relative valuation. Biote Corp Corp (BTMD.O) exhibits a P/S ratio of 0.41, which is 2.7% above the industry average. Given its robust revenue growth of -6.67%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for BTMD
1Y
3Y
5Y
Market capitalization of BTMD increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of BTMD in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is BTMD currently overvalued or undervalued?
Biote Corp (BTMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.41 is considered Fairly compared with the five-year average of 4.09. The fair price of Biote Corp (BTMD) is between 1.66 to 4.82 according to relative valuation methord.
What is Biote Corp (BTMD) fair value?
BTMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Biote Corp (BTMD) is between 1.66 to 4.82 according to relative valuation methord.
How does BTMD's valuation metrics compare to the industry average?
The average P/S ratio for BTMD's competitors is 0.40, providing a benchmark for relative valuation. Biote Corp Corp (BTMD) exhibits a P/S ratio of 0.41, which is 2.70% above the industry average. Given its robust revenue growth of -6.67%, this premium appears unsustainable.
What is the current P/B ratio for Biote Corp (BTMD) as of Jan 10 2026?
As of Jan 10 2026, Biote Corp (BTMD) has a P/B ratio of -1.04. This indicates that the market values BTMD at -1.04 times its book value.
What is the current FCF Yield for Biote Corp (BTMD) as of Jan 10 2026?
As of Jan 10 2026, Biote Corp (BTMD) has a FCF Yield of 43.14%. This means that for every dollar of Biote Corp’s market capitalization, the company generates 43.14 cents in free cash flow.
What is the current Forward P/E ratio for Biote Corp (BTMD) as of Jan 10 2026?
As of Jan 10 2026, Biote Corp (BTMD) has a Forward P/E ratio of 10.74. This means the market is willing to pay $10.74 for every dollar of Biote Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Biote Corp (BTMD) as of Jan 10 2026?
As of Jan 10 2026, Biote Corp (BTMD) has a Forward P/S ratio of 0.41. This means the market is valuing BTMD at $0.41 for every dollar of expected revenue over the next 12 months.